p14Arf and p16Ink4a are barely detectable in normal cells and can be silenced in cancers, consequently measuring differences in protein expression may not differentiate both situations, but epigenetic silencing of these genes should permit to distinguish normal from epigenetically abnormal tumorigenic cells. This evidence concerns the gene CDKN2A and cancer.